Flat Medical Achieves Major Strategic Milestones with EpiFaith® in Europe

Flat Medical, a company renowned for its innovative precision positioning solutions, has recently marked significant progress in the European market with its flagship product, the EpiFaith® Smart Syringe. The company secured major partnerships that are set to transform its operational landscape and expand its reach within the healthcare sector.

Strategic Partnerships and Framework Agreements

On January 13, 2026, Flat Medical announced that it had entered a framework agreement with NHS Supply Chain Coordination Limited (SCCL) in the UK. This partnership represents a noteworthy endorsement from a leading public healthcare system and provides EpiFaith® Smart Syringe access to a vast network of NHS hospitals, kicking off on July 1, 2026. This strategic agreement is anticipated to pave the way for wider adoption across Europe, capitalizing on the NHS's influence in global healthcare standards.

In France, Flat Medical partnered with IDM Medical, further solidifying its European foothold. The collaboration led to a significant clinical order within the Assistance Publique – Hôpitaux de Paris (AP-HP) network, which is known to be the largest hospital system in Europe. This order not only underscores the product's acceptance in prime healthcare institutions but is also expected to catalyze a shift towards standardized procurement processes and increase sales throughout the region.

Dr. Joseph Luo, CEO of Flat Medical, expressed enthusiasm regarding these developments, stating, “The NHS SCCL framework and the AP-HP order represent direct endorsements from world-class institutions. These successes prove that our innovative products can satisfy the high-performance demands of experts while adhering to the economic efficiency requirements of healthcare systems.”

Global Momentum Continues

Flat Medical is not only making waves in Europe but is also experiencing robust growth in other regions. Since 2025, the company has witnessed remarkable sales growth across key markets such as North America, the Middle East, and Japan.

In North America, the company has established indispensable clinical collaborations with prestigious teaching hospitals, pushing sales figures higher. The Middle East market has also entered a promising development stage, with strategic partnerships in the UAE and new orders originating from Israel and Lebanon. In Japan, the company is successfully transitioning towards commercialization based on positive market validation outcomes.

About Flat Medical

Flat Medical is committed to enhancing the precision and safety of needle procedures, developing next-generation solutions for anesthesia and pain management. With operational bases in Taiwan, the USA, and the Netherlands, the firm is dedicated to accelerating the global reach of high-quality medical innovations. The EpiFaith® Smart Syringe stands testament to the company's resolve in improving healthcare outcomes by integrating precision technology that meets modern medical challenges head-on.

As Flat Medical forges ahead, the future looks promising for the EpiFaith® Smart Syringe, marking a pivotal moment in the evolution of medical device solutions. With growing demand and enhanced strategic presence in significant European markets, the company is poised for sustained success and impact.